Introduction {#section1-2150135120949462}
============

The rapid spread of the coronavirus disease 2019 (COVID-19) pandemic has imposed major stresses on health care resources and essentially all aspects of social and economic life around the world.^[@bibr1-2150135120949462]^ Although children, including those with congenital heart disease (CHD), have been relatively spared from the infectious impact of COVID, many colleagues are reporting substantial challenges in running their CHD programs. These challenges include such factors as reductions in staff, equipment, and operating room availability as these resources are reallocated to COVID-19-infected patients or the potential of such patients.^[@bibr2-2150135120949462]^

The COVID-19 pandemic, caused by the novel coronavirus severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), causes mild or no symptoms in 80% of those infected.^[@bibr3-2150135120949462]^ Certain populations, specifically the older age-group with significant underlying cardiopulmonary disorders, have a higher frequency of severe manifestation of the infection, including hospital admission, prolonged cardiorespiratory support, and mortality.^[@bibr4-2150135120949462],[@bibr5-2150135120949462]^ Young adults (18-40 years) and children appear to have a lower incidence of severe disease. However, in a large Chinese pediatric cohort (over 2,000 children), children less than five years old, and especially infants, were more prone to severe disease than other pediatric age groups.^[@bibr6-2150135120949462][@bibr7-2150135120949462]--[@bibr8-2150135120949462]^ Regardless of the populations affected, the pandemic has had an undeniable impact on global health care, with our respective health systems not being adequately prepared to deal with such stresses.

Over the past decade, the potential for such a global plague has become evident though never fully materialized. In 2009 and 2010, the H1N1 "swine flu" pandemic caused thousands of deaths in the United States but never approached the levels seen with COVID-19. According to the Centers for Disease Control and Prevention, from April 12, 2009, to April 10, 2010, there were "60.8 million cases (range: 43.3-89.3 million), 274,304 hospitalizations (range: 195,086-402,719), and 12,469 deaths (range: 8,868-18,306) in the United States due to the (H1N1) pdm09 virus."^[@bibr9-2150135120949462]^

Worldwide, over 14 million individuals have been infected by the novel coronavirus SARS-CoV-2 as of this writing, with 593,000 reported deaths.^[@bibr10-2150135120949462]^ Given this novel viral presentation without the capacity for accurate, widespread testing in the initial phases, these numbers likely are underestimated. Most societies came to a standstill, with "stay-in-place" orders implemented across many countries. Health care systems around the world have essentially shut down normal activities, both to prepare for the care of those infected and because noninfected patients fear acquiring the disease should they enter the hospital environment. Fortunately, several countries that were affected early in this pandemic have succeeded in "flattening the curve" of the viral spread. Some are just beginning to return to a "new normal." The lasting effects of this pandemic, both on the health of humanity and the impact on the global economy, have yet to be realized, but they will be significant.

One of the many concerns when returning to the "new normal" is the impact on patients whose operative correction or palliation was delayed during the imposed closure of congenital heart surgery programs. The possibility that patients present with the deterioration of their clinical condition may have an impact, albeit temporary, on the results in terms of morbidity and mortality and the way surgical schedules can be altered.

The objective of this effort was to assess the impact of the COVID-19 pandemic on both health care systems and individual congenital heart programs across the globe. We report the responses to the first in a series of surveys sent to congenital heart surgeons. This initial survey captured the pandemic's direct impact at the country, institution, and program levels.

Methods {#section2-2150135120949462}
=======

Through a series of conference calls, a list of questions was conceived and refined by an expert panel of internationally recognized pediatric cardiologists, pediatric and congenital heart surgeons from several international organizations, and experts in global health care ([Appendix A](#app1-2150135120949462){ref-type="app"}). The survey consisted of three sections. The first section captured data regarding when the virus first impacted the country and the country's specific public health measures taken to limit the ongoing spread. The second section consisted of questions addressing hospital-specific responses to the pandemic. The final part characterized the impact of the measures imposed by hospitals on the function of the respective congenital heart surgery programs. This was the first of a series of three surveys that will be distributed over the next 12 months. Subsequent surveys will focus on the recovery of the hospital and congenital heart surgery programs and the impact this pandemic has had on patients with CHD. Several of the significant international congenital heart surgery and cardiology societies agreed to distribute the survey to its membership. The surveys were distributed via an online process and collected centrally by the European Congenital Heart Surgeons Association (ECHSA) congenital heart surgery database. Survey responses were tabulated and checked for possible duplicate submissions from the same hospital. In such duplicate responses, wherever (minor) inconsistencies were noted, the department chief's responses were used. All surveys were used, including those with some unanswered questions. Standard descriptive statistics were used to summarize results, where appropriate. Results were presented as aggregate observations.

Results {#section3-2150135120949462}
=======

Distribution of Responses {#section4-2150135120949462}
-------------------------

A total of 202 responses from 176 hospitals in 52 countries were received during the collection period of March 27 to May 4, 2020 ([Figure 1](#fig1-2150135120949462){ref-type="fig"}). More than one surgeon responded from the same hospital in 26 cases. The largest number of responses came from the United States, where 49 hospitals from 24 states participated. The majority of responding hospitals serve both pediatric and adult patients, while 37% (n = 65) were children's hospitals.

![Global responses representing 52 countries, 6 continents.](10.1177_2150135120949462-fig1){#fig1-2150135120949462}

Coronavirus Disease 2019 Pandemic Impact on Countries and Hospitals {#section5-2150135120949462}
-------------------------------------------------------------------

### Social restrictions {#section6-2150135120949462}

Public health-driven societal restrictions intended to inhibit the spread of the COVID-19 infection were nearly universally imposed. Closure of schools and public services such as bars, cafés, restaurants, and sporting facilities were the most common. In only two countries, Nicaragua and Australia, schools were open when the survey response was submitted; and only in three countries (Japan, South Korea, and Sweden), public services remained open. In 73% of the countries (n = 38), citizens were ordered or advised to remain at home and the hospitals discontinued the performance of elective surgical cases. [Figure 2](#fig2-2150135120949462){ref-type="fig"} summarizes the restrictive measures imposed.

![Graphical depiction of the percentage of countries and of individual hospitals in which various restrictive measures described were adopted. Differences shown for various measures between hospital and country reports are due to the fact that, in several countries, more than one center (each with possibly different adopted measures) responded.](10.1177_2150135120949462-fig2){#fig2-2150135120949462}

### Hospital policies {#section7-2150135120949462}

In response to the COVID-19 crisis, hospitals applied different policies regarding patients with COVID-19 (suspected or proven), graphically depicted in [Figure 3](#fig3-2150135120949462){ref-type="fig"}. In a minority of hospitals (n = 31, 17.6%), the policy adopted was to transfer such patients to another hospital. Just over half of the hospitals (n = 96, 54%) accepted and treated patients who came to their emergency departments as needed. Finally, 49 (28%) hospitals were designated as a "Referral Hospital" for patients with COVID-19, meaning that its function had been adapted to preferentially treat patients with COVID-19.

![Hospital policies utilized to triage patients with COVID-19. COVID-19 indicates coronavirus disease 2019.](10.1177_2150135120949462-fig3){#fig3-2150135120949462}

### Patient management {#section8-2150135120949462}

The large majority of hospitals (90%) dedicated spaces for patients with COVID-19 in the wards and intensive care units (ICUs). Rarely (6.3%), patients with COVID-19 were cared for in the same units as non-COVID-19 patients. Elective operations of any kind were cancelled in 91.2% (n = 161) of hospitals, and elective admissions and outpatient clinics were postponed in 85.3% (n = 150) and 78.4% (n = 138), respectively. In most cases, at the time survey responses were submitted, no shortages had been experienced in blood supply (n = 124; 71%), ICU space (n = 151; 86%), or ventilators (n = 166; 95%). Only three hospitals reported using one ventilator to support more than one patient due to ventilator shortages.

### Extracorporeal membrane oxygenation {#section9-2150135120949462}

The availability of extracorporeal membrane oxygenation (ECMO) for patients with COVID-19 was reported in most (n = 158, 90%) of the surveyed hospitals. However, in only 31 (17.6%) of these had ECMO been used at the time of the survey, and only in adult patients suffering from COVID-19 (n = 135). None of the 158 pediatric and congenital heart surgery programs had used ECMO to support pediatric patients (at any age) suspected or diagnosed for COVID-19 infection.

Coronavirus Disease 2019 Pandemic Impact on Congenital Heart Surgery Programs {#section10-2150135120949462}
-----------------------------------------------------------------------------

### Impact on surgeries {#section11-2150135120949462}

In almost half of the programs (n = 81, 46%), the availability of operating rooms and ICU beds was reduced due to the needs of patients with COVID-19. All elective pediatric and congenital heart operations were postponed in 152 (88%) hospitals. Only 21 (12%) institutions reported mild or no impact on surgical schedules. Half of these had been designated as referral departments for patients with CHD during the COVID-19 pandemic. The rest are in countries with different policies in restrictive measures (Sweden, Korea, and Japan), or from hospitals in countries that were either at the "beginning of the curve" (Russia, states in the United States) or "at the end," where restrictions were lifted (Vietnam, Costa Rica). Urgent cases (cases that could not be postponed for more than one month) continued to be operated in 95% of the hospitals. Of the survey responders, the vast majority (85%) believed that postponement of elective surgeries would have a negative impact on their patients who needed cardiac operations or interventions, and they estimate that resumption of elective procedures will be delayed by one to four months (92%). The approximate reduction in the volume of operations performed in participating hospitals, as estimated by the responders, is depicted in [Figure 4](#fig4-2150135120949462){ref-type="fig"}.

![Reported decrease in congenital heart surgery program activities compared to pre-COVID-19 surgical volumes. COVID-19 indicates coronavirus disease 2019.](10.1177_2150135120949462-fig4){#fig4-2150135120949462}

### Impact on staff {#section12-2150135120949462}

In 26% of responses, doctors, nurses, and medical staff from congenital heart surgery programs were required to care for patients with COVID-19. Most congenital heart surgery programs (n = 105; 61%) reported that approximately 10% of their staff were quarantined because of suspected COVID-19 infection. In only 65 (38%) departments there were less than 10% of personnel infected. In most (68%) of the congenital programs, the COVID-19-related reductions in staff did not affect the function of their clinical services. The reduction of congenital program staff according to the cause is depicted in [Figure 5](#fig5-2150135120949462){ref-type="fig"}.

![Congenital heart surgery programmatic practices to manage personnel.](10.1177_2150135120949462-fig5){#fig5-2150135120949462}

### Resumption of elective surgery {#section13-2150135120949462}

At the closure of the response period (May 4, 2020), only 20 congenital programs had resumed elective operations, mainly in Asian countries such as China, South Korea, and India. In 60% of departments, the restrictive situation remained unchanged ([Figure 6](#fig6-2150135120949462){ref-type="fig"}). The estimated time interval required to recover normal operations postpandemic restrictions was one to two months in 43% of the programs and two to four months in 31%, as depicted in [Figure 7](#fig7-2150135120949462){ref-type="fig"}.

![Recovery of congenital heart surgery programs as experienced by congenital heart surgeons.](10.1177_2150135120949462-fig6){#fig6-2150135120949462}

![Estimated period until return of normal clinical activity with congenital heart surgery programs.](10.1177_2150135120949462-fig7){#fig7-2150135120949462}

### Location of treatment for infected patients {#section14-2150135120949462}

The cardiology departments cared for 341 patients with CHD infected with COVID-19. Of these, 38% (n = 129) were treated in home isolation and the rest hospitalized in the wards (n = 122) or the ICU (n = 90). In only five pediatric and congenital programs did COVID-19 positive patients undergo an operation (one patient in each hospital). In four of the five, the outcome was not affected. Furthermore, in 12 hospitals, COVID-19 infection was confirmed during the postoperative period in a total of 19 patients, and in one-third (n = 6) of these, the surgical outcome was adversely affected. Interestingly, the departments that operated on patients with CHD with COVID-19 infection (pre- or postoperatively confirmed) were mainly (13 out of 17) in hospitals that treat both adults and children ([Figure 8](#fig8-2150135120949462){ref-type="fig"}).

![Frequency of patients with COVID-19 with congenital heart disease and type of hospital. COVID-19 indicates coronavirus disease 2019.](10.1177_2150135120949462-fig8){#fig8-2150135120949462}

Comments {#section15-2150135120949462}
========

There is little question that the COVID-19 pandemic has had a significant impact on all aspects of our society. Most countries have shut down all public services and mandated their citizens to abide by restrictive "shelter in place" orders. The global economy has experienced a catastrophic downfall, not experienced since the Great Depression. Many health care systems have been overtaken by the severe virulence of this disease, with hospitals having either been overrun by the volumes of infected patients or implemented closure of services in anticipation of a drain on resources. There appears to be significant geographic variation as to the impact of the virus, with some regions being overwhelmed with significant mortality, while others having been barely affected. The populations affected are now better understood, with age and preinfectious medical conditions having a significant impact on morbidity and mortality. While the virus causes mild or no symptoms in 80% of those infected,^[@bibr1-2150135120949462]^ specific populations (eg, elderly and patients with underlying cardiopulmonary disease) have a higher frequency of severe disease requiring hospital admission, prolonged cardiorespiratory support, and increased mortality.^[@bibr2-2150135120949462],[@bibr3-2150135120949462]^ Young adults (18-40 years) and children appear to have a lower rate of severe disease. However, a large pediatric Chinese cohort (over 2,000 children) demonstrated that those less than five years old, and especially infants, were more prone to severe disease than other pediatric age groups.^[@bibr4-2150135120949462]^ Although the CHD population may not be affected by this disease's virulence, the impact created by the measures taken by countries and individual institutions to both treat those effects and to decrease the spread of the disease has not been defined.

The pediatric and congenital heart surgeons' community is well positioned to assess the impact COVID-19 has had on congenital heart surgery and the measures enacted by their respective institutions. Compared to other medical and surgical specialties, the total numbers of active surgeons are relatively low, allowing the individual relationship to be maintained on a global scale. Organizations as the ECHSA, the World Society for Pediatric and Congenital Heart Surgery, and the Congenital Heart Surgeons Society have a long history of joint meetings, mutual bilateral exchange of knowledge and experience, and prominent cross membership. Accordingly, these societies are uniquely able to mobilize and create processes to rapidly accumulate information related to the COVID-19 pandemic and assess the institutions and congenital heart programs across the globe. These three societies, along with several other listed in [Appendix B](#app2-2150135120949462){ref-type="app"}, worked through a series of video conference calls, conceived, refined, and distributed a survey with a series of questions to capture the pandemic's impact.

Fifty-two countries were represented in the survey, illustrating the global nature of this effort. Universally, public services, including schools, were closed. Most countries (73%) enacted "stay-in-place" practices that persisted at the time of this publication. This observation was consistent with news reports across the globe. It is possible that a universal application of the "stay-at-home" order was not observed as individual countries experiencing the "peak" of the virus asynchronously. Follow-up observations will likely reveal that most countries will have instituted these policies, just at varied periods.

We observed that a majority of hospitals suspended elective operations. These measures were enacted to address either the growing numbers of infected patients requiring care or the potential reallocation of these resources. This is supported by the fact that most of the hospitals' practice was to care for all infected patients admitted or designated as a COVID-19 referral center. Although it was anticipated that there would be a significant shortage in resources within institutions, most responses revealed minimal shortages in the hospital's blood supply, ICU beds, and ventilators at the time of the survey. Most respondents report the ability to provide ECMO support to affected patients. At the time of response, only 17% of institutions had placed a patient with COVID-19 on ECMO, none of which were pediatric patients. As the disease process caused by this virus is becoming better understood, a late presentation in the pediatric population has been described that appears to be related to COVID-19.^[@bibr6-2150135120949462]^ Multisystem inflammatory syndrome in children and adolescents temporally related to COVID-19 is a severe life-threatening multisystem inflammatory condition felt to be like Kawasaki disease and toxic shock syndrome. The impact of PMIS is not yet known but certainly has the potential to increase the need for ECMO in children with COVID-19.

Congenital heart surgery programs enacted similar restrictive measures to prepare for the anticipated loss of personnel and resources, significantly limiting elective procedures in children with CHD. All elective congenital heart surgeries were suspended in most programs across the globe. At the time of the survey, various countries were experiencing different periods on the "curve." For example, South Korea reported a rapid increase in the number of COVID-19 positive patients, immediately enacting social restrictions. This was very early in the global acknowledgment of the existence of a pandemic. This swift action led to rapid control of the virus, with limited mortality, and expedited reopening of congenital heart surgery programs. Seemingly, the restrictions imposed on congenital heart programs may have undefined effects, including patients with CHD experiencing prolonged waiting periods. This is despite the minimal impact on programmatic resources and personnel within most programs, although a minority did report significant impact. Travel restrictions and border closures have also impacted seriously the ability of patients from countries without pediatric cardiac services to receive care either in other countries abroad, or by visiting teams.

Finally, this survey tried to answer an important question: how many of our patients (patients with CHD, followed in our departments or awaiting operation) were suffering from COVID-19 and how did infection affect their treatment? The number of operations performed on infected patients was minimal, and it seems that the outcomes were mildly affected. A more detailed registry of patients with CHD and COVID-19 will be distributed in the next period, focused on clarifying our patients' group and delineating who is affected the most.

Conclusion {#section16-2150135120949462}
==========

The COVID-19 pandemic has already had a dramatic prolonged effect on our entire society. The specific impact on patients with CHD seems to be minimal, compared to the severe disease seen in older patients with underlying comorbidities. What remains unclear is the overall effect the measures enacted to control the virus, specifically, closure of most congenital heart surgery programs for nonemergency operations, will have on patients awaiting corrective or palliative cardiac operations. It would seem that these measures, particularly in children's hospitals, were enacted in part due to a lack of knowledge of how the virus would affect this specific population. Our early data and preliminary experience with the initial wave of infection suggest that the sweeping closure of congenital heart programs may not be necessary during possible future waves of the infection. Perhaps a measured response to closures can be dictated by more objective information which will be accumulated over the next several months.

Limitations {#section17-2150135120949462}
-----------

Studies relying on surveys to gather data are limited by their nature for several reasons. Responses are necessarily restricted to the specific answer choices listed for each question; in addition, individual respondents may interpret questions and answers differently than the survey authors intended. Distributing the survey through multiple scientific societies allows for the swift accumulation of data but does make it difficult to assess the percentage and uniformity of representation for pediatric and congenital heart surgery programs across regions, countries, or continents. This distribution method also does not preclude multiple responses being submitted from the same program. Duplicate submissions were removed from our data after answers were cross-checked for validity and only minor differences were identified. This survey did allow for some questions to be unanswered, and all survey responses were accepted regardless of the completeness of responses.

Perhaps most importantly, this survey provided a time-limited snapshot of a period in an asynchronous global event. This is unavoidable due to the nature of pandemic and the specifics surrounding the transmission of COVID-19; to alleviate this effect, we plan to distribute a series of surveys throughout the next 12 months to capture the evolution of the pandemic adequately. Finally, the ability to draw meaningful conclusions regarding the effect of COVID-19 on patients with CHD is largely precluded due to the very limited number of reports of infected patients.
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CHD

:   congenital heart disease

COVID-19

:   coronavirus disease 2019

ECHSA

:   European Congenital Heart Surgeons Association

ECMO

:   extracorporeal membrane oxygenation

ICU

:   intensive care unit

PMIS

:   pediatric multisystem inflammatory syndrome

SARS-CoV-2

:   severe acute respiratory syndrome coronavirus-2
